A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.
Several professionals said the demand for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Content Removal
According to TikTok, the platform has removed violative content and banned related keywords and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing compliance measures.
Online Trading Operations
Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with images of slimming results, positive reviews and detailed guides for mixing or injecting at residence.
Within moments of joining one community, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Item Details and Pricing
Within these communities, posts display dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to potentially significant health risks”.
